Scarica l'app Stockscreener
8.56
1.27%
-0.11
Dopo l'orario di chiusura:
8.66
0.10
+1.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Shares Decline Amid Transition to Royalty Model - GuruFocus
Novavax rises after six sessions of decline - MSN
Novavax set for a seventh straight decline - MSN
(NVAX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax (NVAX) up 10.4% since last earnings report: Can it continue? - MSN
Novavax, Inc. (NVAX) is attracting investor attention: Here is what you should know - MSN
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore
NVAX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Novavax Q1 2026 slides: partnership revenue surges amid strategic shift - Investing.com
Earnings call transcript: Novavax Q1 2026 beats forecasts, stock surges - Investing.com
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax Inc stock (US6707721049): Q1 2026 results and valuation metrics in focus - AD HOC NEWS
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax, Inc. Trade Ideas — BSESOF:NVV1 - TradingView
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax beats first-quarter revenue estimates on strength in vaccine deals - marketscreener.com
Novo Nordisk opens Czech facility for obesity drugs - marketscreener.com
Novavax rises after strong Q1 beat driven by Pfizer deal - MSN
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. (NVAX) Investors of Filing Deadline in Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Novavax to Participate in 2026 Jefferies Global Healthcare Confe - GuruFocus
Novavax to Participate in 2026 Jefferies Global Healthcare Conference - PR Newswire
Novavax Inc stock (US6707721049): Analyst consensus points to hold as NVAX trades near 11 USD - AD HOC NEWS
Novavax fireside chat at 2026 Jefferies Global Healthcare Conference - Stock Titan
Novavax Stock Soars 13.57%, Hits Intraday High of $10.52 - Markets Mojo
Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Liquidity Mapping Around (NVAX) Price Events - Stock Traders Daily
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc stock (US6707721049): shares trade around USD 10 after recent volatility and licensing f - AD HOC NEWS
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA advisers recommend COVID vaccines be updated to target current dominant variant - Reuters
Novavax Inc stock (US66987V1098): NVAX trades at $11.09 on Nasdaq - AD HOC NEWS
R. Draghia Akli sells 30,000 NVAX shares (NASDAQ: NVAX) - Stock Titan
Why Novavax (NVAX) Stock Is Trading Up Today - Yahoo Finance
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant - Reuters
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
3 Reasons NVAX is Risky and 1 Stock to Buy Instead - Yahoo Finance
Operating margin % of Novavax, Inc. – BSESOF:NVV1 - TradingView
Small-Cap Stocks to Avoid: Peloton, Novavax, and BKV Face Financial RisksNews and Statistics - IndexBox
Why (NVAX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Assessing Novavax (NVAX) Valuation As Trading Swings Revive Investor Interest - Yahoo Finance
2.20%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):